PARATHYROID HORMONE

CHEBI:CHEBI_752256

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1602046
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
route
SUBCUTANEOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BLA
labeler_name
Takeda Pharmaceuticals America, Inc.
manufacturer_name
Takeda Pharmaceuticals America, Inc.
marketing_start_date
20150123
package_marketing_start_date
20150123
nui
N0000180851
pharm_class
Parathyroid Hormone [EPC]
pharm_class_cs
Parathyroid Hormone [CS]
generic_name
PARATHYROID HORMONE
active_ingredient_name
PARATHYROID HORMONE
unii
N19A0T0E5J
pharm_class_epc
Parathyroid Hormone [EPC]
brand_name
NATPARA (parathyroid hormone)
brand_name_base
NATPARA (parathyroid hormone)
product_ndc
68875-0204
application_number
BLA125511
spl_id
c630d391-7567-400e-803c-b3e3bd13c9f5
active_ingredient_strength
75 ug/.08mL
package_ndc
68875-0204-2
package_description
2 CARTRIDGE in 1 CARTON (68875-0204-2) / 1.13 mL in 1 CARTRIDGE (68875-0204-1)
spl_set_id
d11fba31-0a6c-11e3-8ffd-0800200c9a66
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class